Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,714,268
+$3,197,548 QoQ
Shares Held
356,456
+324.3% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 95 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. RNAC ranks #95 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in RNAC

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,714,268 356,456
2026-03-31 $516,720 84,020
2022-06-30 $1,687,213 1,287,949
2022-03-31 $684,426 556,444
2021-12-31 $1,732,448 531,426
2021-09-30 $1,640,550 394,363
2021-06-30 $1,423,636 340,583
2021-03-31 $1,883,336 416,207
2020-12-31 $1,235,176 407,649
2020-09-30 $743,127 299,648